ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs MXN
20.0813
0.02%
Brent Oil
72.72
0.00%
Bitcoin
97,507.69
-0.26%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. EV3 (MM) (EVVV) Cotización

EV3 (MM)

EV3 (MM) (EVVV)

NASDAQ
22.56
0.00
(0.00%)
Cerrado 21 Diciembre 3:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
Fuera de horario: -
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
22.56
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
22.56
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

EVVV Últimas noticias

Más noticias

ev3 Inc. Agrees to Settle Stockholder Litigation

PLYMOUTH, Minn., July 6, 2010 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV), a global endovascular device company, today announced that it has reached an agreement with the plaintiffs to settle the...

06 Julio 2010
GlobeNewswire Inc.

ev3 Announces Acceptance of Pipeline(TM) Embolization Device

PLYMOUTH, Minn., June 21, 2010 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV), a global endovascular device company, today announced that the U.S. Food and Drug Administration (FDA) formally accepted...

21 Junio 2010
GlobeNewswire Inc.

CORRECTING and REPLACING Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Ev3 Inc. by Covidien

Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: BULL & LIFSHITZ, LLP ANNOUNCES INVESTIGATION OF...

09 Junio 2010
Business Wire

Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Ev3 Inc. by Covidien

Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed acquisition of Ev3 Inc.(NASDAQ: EVVV) (referred to as...

09 Junio 2010
Business Wire

Robbins Umeda LLP Announces an Investigation of the Acquisition of ev3 Inc. by Covidien plc

Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of ev3 Inc...

02 Junio 2010
Business Wire

Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of ev3 Inc.

Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of ev3 Inc. (“ev3" or the “Company”) (NASDAQ:EVVV), related...

01 Junio 2010
Business Wire

Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of ev3, Inc. - EVVV

Levi & Korsinsky is investigating the Board of Directors of ev3, Inc. (“ev3” or the “Company”) (NasdaqGS: EVVV) for possible breaches of fiduciary duty and other violations of...

01 Junio 2010
Business Wire

Finkelstein Thompson LLP Announces Investigation of ev3 Inc.

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of ev3 Inc. (“ev3” or the “Company”) (Nasdaq:EVVV) arising from the Company’s announcement...

01 Junio 2010
Business Wire

Kendall Law Group Investigates ev3, Inc. Merger for Shareholders

Kendall Law Group, a national securities firm, is investigating ev3, Inc. (NASDAQ: EVVV) for shareholders in connection with the proposed sale of ev3 to Covidien, plc. (NYSE:...

01 Junio 2010
Business Wire

Tripp Levy PLLC Investigates Proposed Acquisition of ev3

Tripp Levy PLLC announces an investigation into the proposed acquisition of ev3, Inc. (NASDAQ: EVVV). On June 1, 2010, Covidien PLC announced that it is proposing to acquire all...

01 Junio 2010
Business Wire
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

EVVV - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de ?
El precio actual de las acciones de es US$ 22.56
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de ?
ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
120.01M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
76.64M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
33.95M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.61k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
120.4M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
281.23M

EVVV Discussion

Ver más
analogdog analogdog 17 años hace
UPDATE 1-RESEARCH ALERT-Friedman raises Ev3 to outperform
Mon May 5, 2008 8:17am EDT

May 5 (Reuters) - Friedman Billings Ramsey upgraded Ev3 Inc (EVVV.O: Quote, Profile, Research) to "outperform" from "market perform," saying the medical device maker's shares should outperform in the next 12 months as the new chief executive executes on turning around the athrectomy business.

The brokerage, which has a price target of $12 on the stock, said the company's 2008 revenue outlook looks conservative and cost-cutting measures could make Ev3 profitable by the end of 2008.

Shares of Ev3 closed at $8.71 on Nasdaq Friday, when the company posted a wider-than-expected loss in the first quarter. (Reporting by Aditi Samajpati in Bangalore; Editing by Amitha Rajan)
👍️0

Su Consulta Reciente

NASDAQ
EVVV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados